Abstract
The in vitro bactericidal activity of cefazolin was found to be similar to that of cephaloridine and cephalothin but slightly greater than that of cephalexin against a majority of 233 strains of gram-positive and gram-negative organisms. Cefazolin, however, was two- to eightfold more active than the other two drugs against Escherichia coli and klebsiella. The mean peak concentrations in the serum in 10 normal subjects 1 h after intramuscular injections of 1,000, 500, and 250 mg of cefazolin were 38.8, 18.6, and 12.2 mug/ml, respectively. The antibiotic could still be detected at 8 h. Peak values for a given dose of cephaloridine were comparable. However, blood levels of cefazolin were regularly higher than those of cephaloridine over the first 8 h. The mean half-life of cefazolin in the serum was 2 h, whereas that of cephaloridine was 1.4 h. The degree of serum protein-binding was strikingly higher for cefazolin (81%) than for cephaloridine (24%), suggesting that the antibacterial activity of the former in serum might be less than that of cephaloridine after equal doses. This proved to be the case when the bacterial activity of blood drawn 1, 4, and 8 h after injection of the two drugs was examined.
MeSH Terms
Adult
Bacteria/drug effects
Cephalexin/pharmacology
Cephaloridine/pharmacology
Cephalosporins/administration & dosage,blood,pharmacology
Cephalothin/pharmacology
Clinical Trials as Topic
Half-Life
Humans
Injections, Intramuscular
Male
Microbial Sensitivity Tests
Sulfides/administration & dosage,blood,pharmacology
Tetrazoles/administration & dosage,blood,pharmacology
Thiadiazoles/administration & dosage,blood,pharmacology
Chemicals
Cephalosporins
Sulfides
Tetrazoles
Thiadiazoles
Cephaloridine
Cephalexin
Cephalothin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bergeron M G
Brusch J L
Barza M
Weinstein L
References (14)
14 references, click to expand
-
Therapeutic implications of serum protein binding of the new semisynthetic penicillins.
Antimicrob Agents Chemother (Bethesda). 1965;5:1025-34
PMID: 5883398
-
Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
J Antibiot (Tokyo). 1970 Apr;23(4):184-94
PMID: 5423363
-
Cefazolin, a new semisynthetic cephalosporin antibiotic. I. Synthesis and chemical properties of cefazolin.
J Antibiot (Tokyo). 1970 Mar;23(3):131-6
PMID: 5460274
-
Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity.
J Antibiot (Tokyo). 1970 Mar;23(3):137-48
PMID: 4394125
-
In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative.
Antimicrob Agents Chemother (Bethesda). 1969;9:236-43
PMID: 5396493
-
In vitro activity of cephalosporin antibiotics against Gram-positive bacteria.
Postgrad Med J. 1971 Feb;47:Suppl:14-20
PMID: 5556186
-
Clinical studies of cefazolin in the surgical field.
Antimicrob Agents Chemother (Bethesda). 1970;10:467-72
PMID: 4939741
-
Absorption, tissue concentration, and organ distribution of cefazolin.
Antimicrob Agents Chemother (Bethesda). 1970;10:476-80
PMID: 5521371
-
Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.
J Antibiot (Tokyo). 1972 Feb;25(2):86-93
PMID: 5034810
-
In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity.
Chemotherapy. 1973;18(1):7-16
PMID: 4485185
-
Pharmacologic study of cefazolin in volunteers.
J Clin Pharmacol New Drugs. 1973 Feb-Mar;13(2):83-8
PMID: 4631139
-
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
Antimicrob Agents Chemother. 1973 Feb;3(2):168-74
PMID: 4790584
-
Comparative clinical pharmacology of amoxicillin and ampicillin administered orally.
Antimicrob Agents Chemother. 1972 Jun;1(6):504-7
PMID: 4680813
-
Restrictions imposed on antibiotic therapy by renal failure.
Arch Intern Med. 1959 Dec;104:1030-50
PMID: 14412752